Search

Telehealth has emerged as an alternative to conventional, face-to-face visits, and the COVID pandemic has hastened its introduction. Telephone appointments make use of an easy-to-use and accessible technology.To investigate the usability of telephone-based telehealth in a women's health outpatient clinic and whether this may be affected by the severity of the COVID pandemic.A telephone survey was prepared to explore two usability domains: interaction quality (4 items) and satisfaction, preference and future use (6 items). Women were selected from two periods during the COVID pandemic when the infection rates were high and low.The survey was completed by 106 women (60 when the prevalence of COVID was high, mean age 53.58 years, and 46 when it was low, mean age 48.59 years) out of the 153 women who had a telephone appointment. The severity of the COVID pandemic showed an effect on responses. Women were less enthusiastic about using the telephone during the period of low COVID prevalence, as shown by lower scores on 3 of the 4 items of the first domain [I had enough time; I would have understood better in person; I would have expressed myself better in person (p 0.001 for comparison between groups on each of the 3 items)], and on 4 of the 6 items in the second domain [satisfied with quality of care (p 0.001), or with the information received (p = 0.018); use of telephone in future (p 0.001); preference to try other technologies in future (p 0.001)]. Overall, women expressed a preference for in-person visits regardless of COVID prevalence rates.Telephone calls were a feasible alternative to face-to-face visits in a women's health outpatient clinic, but the pandemic pressure modified usability parameters. Respondents preferred in-person visits at any pandemic stage.

Background: In the last years, the identification of different genetic and phenotypic biomarkers for prevention, early diagnostics and patient stratification have been a main objective in cancer research. Different proposals for multivariable models using biomarkers have been presented for the evaluation of individual risk of women to develop breast cancer. Methods: In this study, we describe and evaluate a multivariable model using 92 Single-nucleotide polymorphisms (SNPs) and five different phenotypic variables in a Spanish population of 642 healthy women and 455 breast cancer patients. Results: We were able to stratify both groups with our model. The 9th decile included 1% of controls vs 9% of cases, with an Odds ratio (OR) of 12.9 and a p-value of 3.43E-07. The first decile presented an inverse proportion: 1% of cases and 9% of controls, with an OR of 0.097 and a p-value of 1.86E-08. Conclusions: These results indicate the ability of the multivariable model to stratify women according to their risk to develop breast cancer over a maximum period of 5 years. The analysis present a proof of concept in a poorly studied population and it opens the possibility of using this type of method for routine screening in the Spanish population.

RESUMEN Antecedentes: El embarazo intersticial es muy inusual y representa

Menopause imposes a dramatic fall in estrogens, which is followed by an increase in the proportion of fat. The rising androgen/estrogen ratio along the menopause transition favors the accumulation of central fat, which contributes to insulin resistance and a series of concatenated effects, leading to a higher incidence of metabolic syndrome. The modulatory effect of diet on the metabolic syndrome phenotype has been shown for the Mediterranean diet, and nuts are key determinants of these health benefits. This review of the impact of nuts on the risk factors of the metabolic syndrome cluster examined studies—prioritizing meta-analyses and systemic reviews—to summarize the potential benefits of nut ingestion on the risk of metabolic syndrome associated with menopause. Nuts have a general composition profile that includes macronutrients, with a high proportion of unsaturated fat, bioactive compounds, and fiber. The mechanisms set in motion by nuts have shown different levels of efficacy against the disturbances associated with metabolic syndrome, but a beneficial impact on lipids and carbohydrate metabolism, and a potential, but minimal reduction in blood pressure and fat accumulation have been found.

RESUMEN Antecedentes: El embarazo intersticial es muy inusual y representa

The use of three-dimensional (3D) ultrasonography since the first trimester of pregnancy allows the diagnosis and follow-up of cord entanglement throughout the entire pregnancy and delivery. This technology permits a more accurate diagnosis when compared with two-dimensional (2D) ultrasonography or Doppler The vast majority of cord entanglements observed at the end of the first-trimester will persist during the entire pregnancy; delivery outcome is usually not affected by this finding except for cases in which multiple cord entanglement is diagnosed. How to cite this article Martínez-Aspas A, Raga F, Machado LE, Bonilla F Jr, Castillo JC, Osborne NG, Bonilla-Musoles F. Umbilical Cord Entanglement: Diagnostic and Clinical Repercussions. Donald School J Ultrasound Obstet Gynecol 2012;6(3):225-232.

Resumen El embarazo ectopico intersticial es una entidad rara, que representa el 2-4% de los embarazos ectopicos. Es de dificil diagnostico tanto por su ubicacion como por su rareza. El tratamiento de eleccion es la laparoscopia. Presentamos un caso de embarazo ectopico intersticial en el que la laparoscopia nos sirvio tanto de diagnostico como de tratamiento.

El tumor de Brenner es un tumor raro que representa aproximadamente el 1,5% de los tumores de ovario. Se define como un tumor de células transicionales compuesto por células uroteliales dispuestas en agregados sólidos o quísticos embebidos en un estroma fibroso. Se clasifica en tumor de Brenner benigno (95%), borderline (3-4%) y maligno (1%). Presentamos el caso clínico de una paciente de 91 años intervenida por una tumoración anexial gigante en la que el estudio anatomopatológico reveló la presencia de un tumor de Brenner bilateral benigno asociado a dos cistoadenomas serosos de ovario derecho. Brenner's tumor is a rare tumor that represents approximately 1.5% of the tumors of ovary. It is defined as a tumor of transitional cells composed by cells uroteliales arranged in solid or cystic acccumulations absorbed in a fibrous estroma. It qualifies in tumor of benign Brenner (95%), borderline (3-4%) and malignantly (1%). We present the clinical case of a 91-year-old patient controlled by a giant anexial mass in whom the pathology study (biopsy) revealed the presence of a tumor of bilateral benign Brenner associated with two cistoadenomas serous of right ovary.

El tumor de Brenner es un tumor raro que representa aproximadamente el 1,5% de los tumores de ovario. Se define como un tumor de células transicionales compuesto por células uroteliales dispuestas en agregados sólidos o quísticos embebidos en un estroma fibroso. Se clasifica en tumor de Brenner benigno (95%), borderline (3-4%) y maligno (1%). Presentamos el caso clínico de una paciente de 91 años intervenida por una tumoración anexial gigante en la que el estudio anatomopatológico reveló la presencia de un tumor de Brenner bilateral benigno asociado a dos cistoadenomas serosos de ovario derecho.